Georgia cannabidiol study

9/17/15–Clinical researchers at Georgia Regents University are studying pharmaceutical grade cannibidiol – a specific part of the marijuana plant – to see if the drug has the potential to improve the quality of life for these young patients. The state of Georgia, find along with GW Pharmaceuticals, and officials at GRU have been working together since May to begin a study with GW’s investigational cannabidiol (CBD) product Epidiolex®, which has promising data for difficult to treat childhood epilepsies. Read